July 1st 2009
HFA signs distribution deal with Italian group - Rottapharm / Madaus to be its exclusive UK distributor for Manevac. Madaus remain as MA holder. Manevac is widely prescribed by GP's and is indicated for the treatment of constipation.
July 20th 2009
HFA appoint Pharmexx UK to provide a key account management team to promote Manevac

October 1st 2009
HFA appoint Pharmiweb Solutions to develop an on-line promotional campaign for Manevac

May 20th 2010
HFA signs exclusive distribution deal with Italian group - Rottapharm / Madaus to distribute Glusartel in the UK. Glusartel is the first and only glucosamine sulphate to be licensed by the UK MHRA as a POM.

HFA appoints Pharmexx UK to provide a dedicated Key Account Management team to launch Glusartel 

Welcome to HFA Healthcare Limited

HFA Healthcare is focused on sourcing both established prescription brands which can still demonstrate clear patient benefits yet still benefit from targeted promotion in addition to launching new niche brands.

Faisal Janjua and Paul Johnson, both experienced pharmaceutical executives founded HFA Healthcare in July 2009 after securing the UK rights to Manevac, a widely prescribed constipation brand.

HFA Healthcare has adopted a novel totally virtual infrastructure to house its brands which following a formal audit by the UK MHRA (Medicines and Healthcare products Regulatory Agency) in June 2009 was formally approved and a licence to operate as a pharmaceutical company granted.

Dispensing Doctor Orders
Site Map